Principal Financial Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,976
| Closed | -$262K | – | 2445 |
|
|
2024
Q1 | $262K | Buy |
13,976
+352
| +3% | +$8.12K | ﹤0.01% | 2117 |
|
|
2023
Q4 | $295K | Buy |
13,624
+15
| +0.1% | +$297 | ﹤0.01% | 2070 |
|
|
2023
Q3 | $280K | Sell |
13,609
-138
| -1% | -$3.98K | ﹤0.01% | 2076 |
|
|
2023
Q2 | $646K | Sell |
13,747
-684
| -5% | -$34K | ﹤0.01% | 1909 |
|
|
2023
Q1 | $606K | Buy |
14,431
+2,155
| +18% | +$92.7K | ﹤0.01% | 1931 |
|
|
2022
Q4 | $468K | Buy |
12,276
+67
| +0.5% | +$2.56K | ﹤0.01% | 1994 |
|
|
2022
Q3 | $478K | Buy |
12,209
+2,862
| +31% | +$111K | ﹤0.01% | 1971 |
|
|
2022
Q2 | $302K | Buy |
9,347
+2,482
| +36% | +$83.2K | ﹤0.01% | 2176 |
|
|
2022
Q1 | $227K | Sell |
6,865
-175
| -2% | -$6.58K | ﹤0.01% | 2305 |
|
|
2021
Q4 | $299K | Sell |
7,040
-4,903
| -41% | -$205K | ﹤0.01% | 2246 |
|
|
2021
Q3 | $529K | Sell |
11,943
-5,695
| -32% | -$261K | ﹤0.01% | 2157 |
|
|
2021
Q2 | $1M | Buy |
17,638
+2,176
| +14% | +$154K | ﹤0.01% | 2040 |
|
|
2021
Q1 | $1.16M | Buy |
15,462
+1,464
| +10% | +$120K | ﹤0.01% | 1964 |
|
|
2020
Q4 | $1.21M | Sell |
13,998
-800
| -5% | -$59K | ﹤0.01% | 1902 |
|
|
2020
Q3 | $904K | Buy |
14,798
+3,308
| +29% | +$168K | ﹤0.01% | 1892 |
|
|
2020
Q2 | $478K | Buy |
11,490
+3,522
| +44% | +$128K | ﹤0.01% | 1981 |
|
|
2020
Q1 | $229K | Sell |
7,968
-5,176
| -39% | -$300K | ﹤0.01% | 2036 |
|
|
2019
Q4 | $949K | Sell |
13,144
-271
| -2% | -$33.3K | ﹤0.01% | 1844 |
|
|
2019
Q3 | $1.88M | Sell |
13,415
-543
| -4% | -$90.8K | ﹤0.01% | 1729 |
|
|
2019
Q2 | $2.56M | Buy |
13,958
+1,076
| +8% | +$184K | ﹤0.01% | 1690 |
|
|
2019
Q1 | $2.05M | Sell |
12,882
-10,320
| -44% | -$1.49M | ﹤0.01% | 1733 |
|
|
2018
Q4 | $2.22M | Buy |
23,202
+243
| +1% | +$27.8K | ﹤0.01% | 1703 |
|
|
2018
Q3 | $3.24M | Buy |
22,959
+862
| +4% | +$133K | ﹤0.01% | 1697 |
|
|
2018
Q2 | $3.46M | Buy |
22,097
+9,691
| +78% | +$1.52M | ﹤0.01% | 1676 |
|
|
2018
Q1 | $2M | Buy |
12,406
+382
| +3% | +$64.9K | ﹤0.01% | 1738 |
|
|
2017
Q4 | $1.98M | Buy |
12,024
+6,661
| +124% | +$646K | ﹤0.01% | 1756 |
|
|
2017
Q3 | $334K | Sell |
5,363
-963
| -15% | -$75.6K | ﹤0.01% | 2007 |
|
|
2017
Q2 | $504K | Buy |
6,326
+703
| +13% | +$50.8K | ﹤0.01% | 1946 |
|
|
2017
Q1 | $400K | Buy |
5,623
+62
| +1% | +$3.63K | ﹤0.01% | 1955 |
|
|
2016
Q4 | $284K | Buy |
5,561
+847
| +18% | +$39.9K | ﹤0.01% | 2024 |
|
|
2016
Q3 | $217K | Buy |
+4,714
| New | +$192K | ﹤0.01% | 2027 |
|
Other funds holding SAGE
RI
BG